← Strata Critical Medical, Inc.
| Annual Trend | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|
| Net income / (loss) | ($10.8m) | ($10.2m) | ($40.1m) | ($27.3m) | ($56.1m) | ($27.3m) | $41.3m | — | |
| Depreciation and amortization | $472k | $526k | $596k | $5.7m | $7.1m | $6.0m | $8.2m | $16.3m | |
| Amortization Cash Flow | — | — | — | — | $6.0m | $3.0m | — | — | |
| Amortization Of Intangibles | — | — | — | — | $6.0m | $3.0m | — | — | |
| Depreciation Amortization Depletion | — | — | — | $5.7m | $7.1m | $6.0m | $8.2m | $16.3m | |
| Deferred tax expense (benefit) | $0 | $0 | ($3.6m) | ($772k) | ($1.5m) | ($255k) | $432k | — | |
| Deferred Income Tax | — | — | — | ($772k) | ($1.5m) | ($255k) | $432k | $332k | |
| Stock-based compensation | $317k | $490k | $9.6m | $8.3m | $12.5m | $19.9m | $17.8m | $17.0m | |
| Impairment of intangible assets | — | — | — | — | $20.8m | $5.8m | $0 | — | |
| Impairment of property and equipment | $28k | $0 | $0 | $68k | $138k | $0 | $1.7m | — | |
| Asset Impairment Charge | — | — | — | $0 | $20.9m | $5.8m | $1.7m | $1.7m | |
| Change In Working Capital | — | — | — | ($17k) | ($6.7m) | ($3.0m) | ($9.1m) | ($7.1m) | |
| Accounts receivable | ($165k) | ($591k) | ($414k) | ($5.3m) | ($10.3m) | ($998k) | ($12.0m) | ($5.8m) | |
| Change In Receivables | — | — | — | ($5.3m) | ($10.3m) | ($998k) | ($12.0m) | ($5.8m) | |
| Changes In Account Receivables | — | — | — | ($5.3m) | ($10.3m) | ($998k) | ($12.0m) | ($5.8m) | |
| Accounts payable and accrued expenses | $0 | $22k | ($482k) | $0 | $9.0m | ($8.3m) | $2.4m | — | |
| Contingent consideration in accounts payable and accrued expenses and other non-current liabilities | — | — | — | — | — | $0 | $9.1m | — | |
| Purchases of property and equipment and capitalized software in accounts payable and accrued expenses | — | — | — | — | $0 | $375k | $128k | ($13.5m) | |
| Common stock issued for settlement of earn-out previously in accounts payable and accrued expenses | — | — | — | — | $1.8m | $3.0m | $0 | — | |
| Change In Payables And Accrued Expense | — | — | — | $9.9m | $9.0m | ($8.3m) | $2.4m | ($1.2m) | |
| Deferred revenue | $721k | $645k | $681k | $737k | $117k | ($119k) | $1.7m | — | |
| Change in fair value of assets and other liabilities | — | — | — | — | — | $0 | $1.0m | — | |
| Other | $0 | $0 | $1k | — | $46k | ($12k) | $471k | — | |
| Prepaid expenses and other current assets | $0 | $0 | $90k | $0 | ($6.0m) | $6.4m | ($1.7m) | — | |
| Contingent consideration and indemnity holdback receivable from sale of business in prepaids and other current assets and other non-current assets, respectively | — | — | — | — | — | $0 | $36.4m | — | |
| Change In Other Current Assets | — | — | — | ($663k) | $4k | ($70k) | $666k | $669k | |
| Net cash used in operating activities | ($10.3m) |
($794k)
+92.29%
|
($15.6m)
-1865.47%
|
($37.1m)
-137.78%
|
($32.3m)
+12.88%
|
($2.5m)
+92.21%
|
($48.9m)
-1841.80%
|
($36.0m)
+26.34%
|
|
| Purchase of property and equipment, net of proceeds from disposal | ($604k) | ($377k) | ($297k) | ($730k) | ($2.1m) | ($30.9m) | ($9.6m) | ($13.5m) | |
| Capital Expenditure Reported | — | — | — | — | $0 | ($2.1m) | ($1.4m) | ($13.5m) | |
| Realized loss from sale of short-term investments | — | — | $0 | $2.2m | ($8k) | $0 | $5.2m | — | |
| Purchase of held-to-maturity investments | — | — | $0 | ($227.3m) | ($265.8m) | ($143.3m) | ($146.3m) | — | |
| Proceeds from maturities of held-to-maturity investments | — | — | $0 | $98.0m | $264.5m | $177.4m | $226.2m | — | |
| Proceeds from sale of short-term investments | $0 | $0 | $11.3m | $258.4m | $20.5m | $0 | $70.2m | — | |
| Acquisitions, net of cash acquired | $0 | $0 | ($23.1m) | ($48.1m) | $0 | ($2.2m) | ($66.5m) | ($104.5m) | |
| Net cash provided by / (used in) investing activities (includes discontinued operations; see Note 5) | ($1.1m) | $335k | ($321.3m) | $79.3m | $17.1m | ($1.0m) | $69.8m | $1.5m | |
| Long Term Debt Payments | — | — | ($1.2m) | $0 | — | — | — | — | |
| Net Issuance Payments Of Debt | — | — | ($1.2m) | $0 | — | — | — | — | |
| Net Long Term Debt Issuance | — | — | ($1.2m) | $0 | — | — | — | — | |
| Repayment Of Debt | — | — | ($1.2m) | $0 | — | — | — | — | |
| Proceeds from the exercise of common stock options | $116k | $15k | $144k | $87k | $70k | $168k | $193k | — | |
| Repurchase and retirement of common stock | — | — | — | — | $0 | ($244k) | $0 | — | |
| Common stock received for sale of business | — | — | — | — | — | $0 | $75.4m | — | |
| Common stock issued for acquisition | — | — | — | — | — | $0 | $8.4m | — | |
| Common Stock Issuance | — | — | $119.6m | $0 | $0 | ($244k) | $0 | — | |
| Common Stock Payments | — | — | — | — | $0 | ($244k) | $0 | $0 | |
| Issuance Of Capital Stock | — | — | $119.6m | $0 | — | — | — | — | |
| Repurchase Of Capital Stock | — | — | — | — | $0 | ($244k) | $0 | $0 | |
| Taxes paid related to net share settlement of equity awards | $0 | $0 | ($52k) | ($1.2m) | ($146k) | ($5.7m) | ($9.1m) | — | |
| Net Other Financing Charges | — | — | — | ($1.2m) | ($146k) | ($5.7m) | ($9.1m) | ($8.8m) | |
| Net cash used in financing activities | $116k |
$1.2m
+917.24%
|
$332.3m
+28057.54%
|
($1.1m)
-100.33%
|
($76k)
+92.99%
|
($5.8m)
-7477.63%
|
($8.9m)
-54.75%
|
($8.6m)
+3.50%
|
|
| Net increase (decrease) in cash and cash equivalents and restricted cash | ($11.2m) | ($460k) | ($4.7m) | $41.2m | ($15.4m) | ($9.4m) | $11.6m | — | |
| Cash and cash equivalents and restricted cash - beginning | $1.3m | $846k | $7.6m | $44.4m | $29.0m | $19.6m | $31.2m | — | |
| Beginning Cash Position | — | — | — | $3.2m | $44.4m | $29.0m | $19.6m | $60.3m | |
| Restricted cash | $114k | $114k | $630k | $1.1m | $1.1m | $1.3m | $264k | — | |
| Effect of foreign exchange rate changes on cash balances | — | — | $0 | $72k | ($66k) | ($80k) | ($339k) | — | |
| Effect Of Exchange Rate Changes | — | — | — | $72k | ($66k) | ($80k) | ($339k) | ($616k) | |
| Additional Supplementary Disclosures | |||||||||
| Additional Supplementary Disclosures | |||||||||
| Gain on sale of business | — | — | — | — | — | $0 | ($57.0m) | — | |
| Change in fair value of warrant liabilities | $0 | $0 | $18.3m | ($24.2m) | ($2.1m) | $850k | ($4.3m) | — | |
| Excess of lease liability over operating right-of-use assets | — | — | — | — | $0 | ($123k) | $0 | — | |
| Transaction costs paid related to sale of business | — | — | — | — | — | $0 | ($7.4m) | — | |
| Gain on lease modification | — | — | — | — | $0 | ($622k) | $0 | — | |
| Acquisition consideration allocated to seller transaction expenses | — | — | — | — | — | $0 | ($44.3m) | — | |
| Realized foreign exchange gain | — | — | — | — | — | $0 | ($798k) | — | |
| Accretion of interest income on held-to-maturity securities | — | — | $0 | ($1.1m) | ($6.5m) | ($4.0m) | ($2.2m) | — | |
| Other non-current assets | ($93k) | $17k | ($119k) | ($663k) | $4k | ($70k) | $666k | — | |
| Operating right-of-use assets/lease liabilities | ($27k) | $11k | $3k | $611k | $379k | $164k | ($88k) | — | |
| Cash transfer from sale of business | — | — | — | — | — | $0 | ($2.8m) | — | |
| Capitalized software development costs | ($250k) | $0 | ($504k) | $0 | $0 | ($2.1m) | ($1.4m) | — | |
| Cash and cash equivalents | $22.2m | $12.2m | $7.0m | $43.3m | $27.9m | $18.4m | $31.0m | $60.3m | |
| Income Taxes paid | $0 | $0 | $0 | $0 | $16k | $0 | $87k | — | |
| New leases under ASC 842 entered into during the period | $512k | $788k | $13k | $6.4m | $9.8m | $8.4m | $1.6m | — | |
| Modification of existing right-of-use assets ("ROU") and lease liability | — | — | — | — | $0 | $12.7m | $0 | — | |
| Derecognition of ROU assets and lease liability | — | — | — | — | $0 | ($6.4m) | $0 | — | |
| Cash Flow From Continuing Financing Activities | — | — | — | ($1.1m) | ($76k) | ($5.8m) | ($8.9m) | ($8.6m) | |
| Cash Flow From Continuing Investing Activities | — | — | — | $79.3m | $17.1m | ($1.0m) | $69.8m | $1.5m | |
| Change In Cash Supplemental As Reported | — | — | — | $41.2m | ($15.4m) | ($9.4m) | $11.6m | — | |
| Change In Other Working Capital | — | — | — | $1.3m | $496k | $45k | $1.6m | ($535k) | |
| Change In Prepaid Assets | — | — | — | ($5.3m) | ($6.0m) | $6.4m | ($1.7m) | ($230k) | |
| Changes In Cash | — | — | — | $41.1m | ($15.3m) | ($9.3m) | $11.9m | ($43.1m) | |
| End Cash Position | — | — | — | $44.4m | $29.0m | $19.6m | $31.2m | $17.2m | |
| Financing Cash Flow | — | — | — | ($1.1m) |
($76k)
+92.99%
|
($5.8m)
-7477.63%
|
($8.9m)
-54.75%
|
($8.6m)
+3.50%
|
|
| Free Cash Flow | — | — | — | ($37.9m) | ($34.5m) | ($35.5m) | ($59.9m) | ($49.5m) | |
| Gain Loss On Investment Securities | — | — | — | ($22.1m) | ($2.1m) | $850k | $917k | $2.2m | |
| Gain Loss On Sale Of Business | — | — | — | — | — | $0 | ($57.0m) | ($56.7m) | |
| Gain Loss On Sale Of PPE | — | — | $0 | $68k | $48k | — | — | — | |
| Interest Paid Supplemental Data | — | — | $12k | $0 | — | — | — | — | |
| Investing Cash Flow | — | — | — | $79.3m | $17.1m | ($1.0m) | $69.8m | $1.5m | |
| Net Business Purchase And Sale | — | — | — | ($48.3m) | ($39k) | ($2.2m) | ($69.3m) | ($104.5m) | |
| Net Foreign Currency Exchange Gain Loss | — | — | — | $6k | $6k | $0 | ($798k) | ($798k) | |
| Net Intangibles Purchase And Sale | — | — | ($504k) | $0 | — | — | — | ($1k) | |
| Net Investment Purchase And Sale | — | — | — | $128.4m | $19.1m | $34.2m | $150.1m | $119.5m | |
| Net PPE Purchase And Sale | — | — | — | ($730k) | ($2.0m) | ($30.9m) | ($9.6m) | ($12.4m) | |
| Operating Gains Losses | — | — | — | ($22.0m) | ($2.1m) | $850k | ($56.9m) | ($55.2m) | |
| Other Non Cash Items | — | — | — | ($1.1m) | ($6.5m) | ($4.4m) | ($52.4m) | — | |
| Proceeds From Stock Option Exercised | — | — | — | $87k | $70k | $168k | $193k | $174k | |
| Purchase Of Business | — | — | — | ($48.3m) | ($39k) | ($2.2m) | ($69.3m) | ($104.5m) | |
| Purchase Of Intangibles | — | — | ($504k) | $0 | — | — | — | ($1k) | |
| Purchase Of Investment | — | — | — | ($228.0m) | ($266.0m) | ($143.3m) | ($146.3m) | ($56.1m) | |
| Purchase Of PPE | — | — | $224k | ($730k) | ($2.1m) | ($30.9m) | ($9.6m) | ($13.5m) | |
| Sale Of Investment | — | — | — | $356.4m | $285.1m | $177.4m | $296.4m | $175.6m | |
| Sale Of PPE | — | — | — | $0 | $138k | $13k | — | $82k |